<p>随着全球市场在波动的利率和经济指标的复杂环境中航行，小盘股展现出韧性，受益于近期对潜在降息的希望。在这种环境下，识别未被发现的投资机会变得至关重要，因为这些股票通常具有独特的增长潜力，并能在更广泛的市场不确定性中蓬勃发展。</p>
<h3>全球十大基本面强劲的未被发现的投资机会</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>狮子岩集团</td>
<td>5.00%</td>
<td>14.21%</td>
<td>13.26%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>自然食品国际控股</td>
<td>NA</td>
<td>8.04%</td>
<td>37.71%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>VICOM</td>
<td>NA</td>
<td>6.95%</td>
<td>4.06%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>达芙妮国际控股</td>
<td>NA</td>
<td>-5.92%</td>
<td>82.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>HG 金属制造</td>
<td>3.75%</td>
<td>8.47%</td>
<td>6.94%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>太洋化学有限公司</td>
<td>0.67%</td>
<td>5.77%</td>
<td>2.06%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>CTCI 先进系统</td>
<td>33.93%</td>
<td>20.38%</td>
<td>21.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>中国新城市集团</td>
<td>85.52%</td>
<td>30.33%</td>
<td>17.38%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>李铭发展建设</td>
<td>170.96%</td>
<td>14.13%</td>
<td>22.83%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Practic</td>
<td>NA</td>
<td>4.86%</td>
<td>6.64%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们全球基本面强劲的未被发现的投资机会筛选器中的 2946 只股票的完整列表。</p>
<p>我们将从我们的筛选结果中考察一些选项。</p>
<h2>上海耀华皮尔金顿玻璃集团 (SHSE:600819)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 上海耀华皮尔金顿玻璃集团有限公司在玻璃制造行业运营，市值为 54.1 亿人民币。</p>
<p><strong>运营：</strong> 该公司主要通过其玻璃制造业务产生收入。净利润率显示出波动，反映出运营效率和市场条件的变化。</p>
<p>作为玻璃行业中的小型参与者，上海耀华皮尔金顿玻璃集团展现出令人印象深刻的财务韧性。最近，其盈利增长了 282.5%，远超基础材料行业的 21.2% 增长率。公司的负债权益比在五年内显著改善，从 21% 降至 12.2%，表明其财务管理谨慎。尽管截至 2025 年 6 月的半年销售额从 27.5 亿人民币下降至 26.18 亿人民币，但净收入从去年的 6300 万人民币上升至 8600 万人民币。由于利息支付由 EBIT 以 19 倍的强劲倍数覆盖，且报告的盈利质量高，上海耀华似乎在市场波动中有望保持稳定。</p>
<ul>
<li>通过我们的综合健康报告深入了解上海耀华皮尔金顿玻璃集团的复杂情况。</li>
<li>探索历史数据，以跟踪上海耀华皮尔金顿玻璃集团的表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b06a1b8b-78d5-4a8f-b6fd-257b19781141/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b06a1b8b-78d5-4a8f-b6fd-257b19781141/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 9 月的 SHSE:600819 负债权益比</p>
<h2>振德医疗 (SHSE:603301)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 振德医疗有限公司专注于中国医疗护理和防护设备的研究、开发、生产和销售，市值为 71.9 亿人民币。</p>
<p><strong>运营：</strong> 振德医疗通过销售医疗护理和防护设备产生收入。公司的财务表现以净利润率为特征，反映其运营效率。</p>
<p>作为医疗设备行业中的小型参与者，振德医疗在过去一年中展现出 188% 的令人印象深刻的盈利增长，超越了行业同行。尽管 2025 年上半年净收入较去年的 1.6111 亿人民币下降至 1.2776 亿人民币，但其债务管理强劲，利息支付由 EBIT 覆盖 341 倍，负债权益比在五年内从 32.3% 降至 24%。以被认为低于公允价值 32% 的价格交易，表明潜在的上涨空间，同时其在沙特的合资工厂等战略举措增强了区域市场的存在感和未来前景。</p>
<ul>
<li>在此健康报告中解锁我们对振德医疗股票分析的全面见解。</li>
<li>通过检查我们的历史报告了解振德医疗的业绩记录。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f41794d2-9dc2-480b-8e63-913d5fdf0722/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f41794d2-9dc2-480b-8e63-913d5fdf0722/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 9 月的 SHSE:603301 负债权益比</p>
<h2>Convano (TSE:6574)</h2>
<p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Convano Inc. 在日本经营美甲沙龙的管理和特许经营，市值为 1031.7 亿日元。</p>
<p><strong>运营：</strong> Convano 主要通过其美甲业务产生收入，贡献 30.9 亿日元，此外，医疗保健和投资顾问部门分别贡献 1.0041 亿日元和 5529 万日元。</p>
<p>Convano 已成为一个充满活力的参与者，最近实现了盈利，并展现出强劲的财务健康。公司的负债权益比在五年内显著下降，从 45.9% 降至 20.5%，表明其有效的债务管理。尽管最近几个月股价波动剧烈，但利息支付由 EBIT 以 17.9 倍的倍数覆盖，Convano 的财务稳定性显而易见。该公司完成了一次重大股票拆分和私募，筹集了 60 亿日元用于战略举措，行使期延长至 2027 年 7 月。这些发展表明 Convano 正在为未来的行业增长做好准备。</p>
<ul>
<li>在此深入了解 Convano 的完整分析健康报告。</li>
<li>查看我们的历史业绩报告，以获取 Convano 过去表现的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b5c2da5f-4530-48cb-af0c-006c3ddd465b/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b5c2da5f-4530-48cb-af0c-006c3ddd465b/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 9 月的 TSE:6574 负债权益比</p>
<h2>下一步</h2>
<ul>
<li>在这里开始您的投资之旅，探索我们 2946 个具有强大基本面的全球未被发现的投资宝藏。</li>
<li>拥有这些公司的股份？将您的持股整合到 Simply Wall St 的投资组合中，以获取通知和详细的股票报告。</li>
<li>通过使用 Simply Wall St，加入聪明投资者的社区。它是免费的，并提供全球市场的专家级分析。</li>
</ul>
<h2>寻找其他投资机会？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力可观但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>

振德医疗

<p>这篇文章讨论了小盘股在波动的全球市场中的韧性，强调了上海耀华皮尔金顿玻璃集团和振德医疗作为有前景的投资。上海耀华展现了 282.5% 的令人印象深刻的盈利增长和改善的债务管理，而振德医疗则在净收入略有下降的情况下报告了 188% 的盈利增长。这两家公司都具备稳定和增长的潜力，强大的基本面和战略举措增强了它们的市场存在感。文章强调了在当前经济环境中识别未被发现的投资机会的重要性</p>

<p>As global markets navigate a complex landscape marked by fluctuating interest rates and economic indicators, smaller-cap stocks have shown resilience, benefiting from recent hopes of potential rate cuts. In this environment, identifying undiscovered gems becomes crucial, as these stocks often possess unique growth potential and can thrive amid broader market uncertainties.</p>
<div class="lb-trans"><p>随着全球市场在波动的利率和经济指标的复杂环境中航行，小盘股展现出韧性，受益于近期对潜在降息的希望。在这种环境下，识别未被发现的投资机会变得至关重要，因为这些股票通常具有独特的增长潜力，并能在更广泛的市场不确定性中蓬勃发展。</p>
</div><h3>Top 10 Undiscovered Gems With Strong Fundamentals Globally</h3>
<div class="lb-trans"><h3>全球十大基本面强劲的未被发现的投资机会</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Debt To Equity</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Health Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lion Rock Group</td>
<td>5.00%</td>
<td>14.21%</td>
<td>13.26%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Natural Food International Holding</td>
<td>NA</td>
<td>8.04%</td>
<td>37.71%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>VICOM</td>
<td>NA</td>
<td>6.95%</td>
<td>4.06%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Daphne International Holdings</td>
<td>NA</td>
<td>-5.92%</td>
<td>82.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>HG Metal Manufacturing</td>
<td>3.75%</td>
<td>8.47%</td>
<td>6.94%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Taiyo KagakuLtd</td>
<td>0.67%</td>
<td>5.77%</td>
<td>2.06%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>CTCI Advanced Systems</td>
<td>33.93%</td>
<td>20.38%</td>
<td>21.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>China New City Group</td>
<td>85.52%</td>
<td>30.33%</td>
<td>17.38%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Li Ming Development Construction</td>
<td>170.96%</td>
<td>14.13%</td>
<td>22.83%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Practic</td>
<td>NA</td>
<td>4.86%</td>
<td>6.64%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>负债权益比</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>健康评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>狮子岩集团</td>
<td>5.00%</td>
<td>14.21%</td>
<td>13.26%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>自然食品国际控股</td>
<td>NA</td>
<td>8.04%</td>
<td>37.71%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>VICOM</td>
<td>NA</td>
<td>6.95%</td>
<td>4.06%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>达芙妮国际控股</td>
<td>NA</td>
<td>-5.92%</td>
<td>82.03%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>HG 金属制造</td>
<td>3.75%</td>
<td>8.47%</td>
<td>6.94%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>太洋化学有限公司</td>
<td>0.67%</td>
<td>5.77%</td>
<td>2.06%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>CTCI 先进系统</td>
<td>33.93%</td>
<td>20.38%</td>
<td>21.25%</td>
<td>★★★★★☆</td>
</tr>
<tr>
<td>中国新城市集团</td>
<td>85.52%</td>
<td>30.33%</td>
<td>17.38%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>李铭发展建设</td>
<td>170.96%</td>
<td>14.13%</td>
<td>22.83%</td>
<td>★★★★☆☆</td>
</tr>
<tr>
<td>Practic</td>
<td>NA</td>
<td>4.86%</td>
<td>6.64%</td>
<td>★★★★☆☆</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 2946 stocks from our Global Undiscovered Gems With Strong Fundamentals screener.</p>
<div class="lb-trans"><p>点击这里查看我们全球基本面强劲的未被发现的投资机会筛选器中的 2946 只股票的完整列表。</p>
</div><p>We'll examine a selection from our screener results.</p>
<div class="lb-trans"><p>我们将从我们的筛选结果中考察一些选项。</p>
</div><h2>Shanghai Yaohua Pilkington Glass Group (SHSE:600819)</h2>
<div class="lb-trans"><h2>上海耀华皮尔金顿玻璃集团 (SHSE:600819)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Shanghai Yaohua Pilkington Glass Group Co., Ltd. operates in the glass manufacturing industry and has a market capitalization of CN¥5.41 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 上海耀华皮尔金顿玻璃集团有限公司在玻璃制造行业运营，市值为 54.1 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its glass manufacturing operations. The net profit margin has shown fluctuations, reflecting changes in operational efficiency and market conditions.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其玻璃制造业务产生收入。净利润率显示出波动，反映出运营效率和市场条件的变化。</p>
</div><p>Shanghai Yaohua Pilkington Glass Group, a smaller player in the glass industry, has shown impressive financial resilience. Recently, its earnings surged by 282.5%, far outpacing the Basic Materials industry's 21.2% growth rate. The company's debt to equity ratio improved significantly from 21% to 12.2% over five years, indicating prudent financial management. Despite a slight dip in sales from CNY 2,750 million to CNY 2,618 million for the half-year ending June 2025, net income rose to CNY 86 million from CNY 63 million last year. With interest payments well covered by EBIT at a robust factor of 19x and high-quality earnings reported, Shanghai Yaohua seems poised for continued stability amidst market fluctuations.</p>
<div class="lb-trans"><p>作为玻璃行业中的小型参与者，上海耀华皮尔金顿玻璃集团展现出令人印象深刻的财务韧性。最近，其盈利增长了 282.5%，远超基础材料行业的 21.2% 增长率。公司的负债权益比在五年内显著改善，从 21% 降至 12.2%，表明其财务管理谨慎。尽管截至 2025 年 6 月的半年销售额从 27.5 亿人民币下降至 26.18 亿人民币，但净收入从去年的 6300 万人民币上升至 8600 万人民币。由于利息支付由 EBIT 以 19 倍的强劲倍数覆盖，且报告的盈利质量高，上海耀华似乎在市场波动中有望保持稳定。</p>
</div><ul>
<li>Navigate through the intricacies of Shanghai Yaohua Pilkington Glass Group with our comprehensive health report here.</li>
<li>Explore historical data to track Shanghai Yaohua Pilkington Glass Group's performance over time in our Past section.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过我们的综合健康报告深入了解上海耀华皮尔金顿玻璃集团的复杂情况。</li>
<li>探索历史数据，以跟踪上海耀华皮尔金顿玻璃集团的表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b06a1b8b-78d5-4a8f-b6fd-257b19781141/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/b06a1b8b-78d5-4a8f-b6fd-257b19781141/chart/debt-equity-history-analysis"/></p>
<p>SHSE:600819 Debt to Equity as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SHSE:600819 负债权益比</p>
</div><h2>Zhende Medical (SHSE:603301)</h2>
<div class="lb-trans"><h2>振德医疗 (SHSE:603301)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Zhende Medical Co., Ltd. focuses on the research, development, production, and sale of medical care and protective equipment in China with a market capitalization of CN¥7.19 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 振德医疗有限公司专注于中国医疗护理和防护设备的研究、开发、生产和销售，市值为 71.9 亿人民币。</p>
</div><p><strong>Operations:</strong> Zhende Medical generates revenue from the sale of medical care and protective equipment. The company's financial performance is characterized by a net profit margin that reflects its operational efficiency.</p>
<div class="lb-trans"><p><strong>运营：</strong> 振德医疗通过销售医疗护理和防护设备产生收入。公司的财务表现以净利润率为特征，反映其运营效率。</p>
</div><p>Zhende Medical, a smaller player in the medical equipment sector, has shown impressive earnings growth of 188% over the past year, outpacing industry peers. Despite a dip in net income to CN¥127.76 million for the first half of 2025 compared to CN¥161.11 million last year, its debt management is strong with interest payments covered 341 times by EBIT and a reduced debt-to-equity ratio from 32.3% to 24% over five years. Trading at a value perceived as 32% below fair value suggests potential upside while its strategic ventures like the Saudi joint factory enhance regional market presence and future prospects.</p>
<div class="lb-trans"><p>作为医疗设备行业中的小型参与者，振德医疗在过去一年中展现出 188% 的令人印象深刻的盈利增长，超越了行业同行。尽管 2025 年上半年净收入较去年的 1.6111 亿人民币下降至 1.2776 亿人民币，但其债务管理强劲，利息支付由 EBIT 覆盖 341 倍，负债权益比在五年内从 32.3% 降至 24%。以被认为低于公允价值 32% 的价格交易，表明潜在的上涨空间，同时其在沙特的合资工厂等战略举措增强了区域市场的存在感和未来前景。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Zhende Medical stock in this health report.</li>
<li>Understand Zhende Medical's track record by examining our Past report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在此健康报告中解锁我们对振德医疗股票分析的全面见解。</li>
<li>通过检查我们的历史报告了解振德医疗的业绩记录。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f41794d2-9dc2-480b-8e63-913d5fdf0722/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/f41794d2-9dc2-480b-8e63-913d5fdf0722/chart/debt-equity-history-analysis"/></p>
<p>SHSE:603301 Debt to Equity as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SHSE:603301 负债权益比</p>
</div><h2>Convano (TSE:6574)</h2>
<div class="lb-trans"><h2>Convano (TSE:6574)</h2>
</div><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 价值评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Convano Inc. operates in the management and franchising of nail salons in Japan with a market capitalization of ¥103.17 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Convano Inc. 在日本经营美甲沙龙的管理和特许经营，市值为 1031.7 亿日元。</p>
</div><p><strong>Operations:</strong> Convano generates revenue primarily from its Nail Business, which contributes ¥3.09 billion, supplemented by the Healthcare and Investment and Advisory segments with ¥100.41 million and ¥55.29 million respectively.</p>
<div class="lb-trans"><p><strong>运营：</strong> Convano 主要通过其美甲业务产生收入，贡献 30.9 亿日元，此外，医疗保健和投资顾问部门分别贡献 1.0041 亿日元和 5529 万日元。</p>
</div><p>Convano has emerged as a dynamic player, recently achieving profitability and showcasing robust financial health. The company's debt to equity ratio impressively decreased from 45.9% to 20.5% over five years, indicating effective debt management. With interest payments well covered by EBIT at 17.9 times, Convano's financial stability is evident despite a highly volatile share price in recent months. The firm completed a significant stock split and private placement, raising ¥6 billion for strategic initiatives with an exercise period extending until July 2027. These developments suggest Convano is positioning itself for future growth within its industry landscape.</p>
<div class="lb-trans"><p>Convano 已成为一个充满活力的参与者，最近实现了盈利，并展现出强劲的财务健康。公司的负债权益比在五年内显著下降，从 45.9% 降至 20.5%，表明其有效的债务管理。尽管最近几个月股价波动剧烈，但利息支付由 EBIT 以 17.9 倍的倍数覆盖，Convano 的财务稳定性显而易见。该公司完成了一次重大股票拆分和私募，筹集了 60 亿日元用于战略举措，行使期延长至 2027 年 7 月。这些发展表明 Convano 正在为未来的行业增长做好准备。</p>
</div><ul>
<li>Delve into the full analysis health report here for a deeper understanding of Convano.</li>
<li>Review our historical performance report to gain insights into Convano's's past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>在此深入了解 Convano 的完整分析健康报告。</li>
<li>查看我们的历史业绩报告，以获取 Convano 过去表现的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/b5c2da5f-4530-48cb-af0c-006c3ddd465b/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/b5c2da5f-4530-48cb-af0c-006c3ddd465b/chart/debt-equity-history-analysis"/></p>
<p>TSE:6574 Debt to Equity as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 TSE:6574 负债权益比</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><ul>
<li>Embark on your investment journey to our 2946 Global Undiscovered Gems With Strong Fundamentals selection here.</li>
<li>Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.</li>
<li>Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里开始您的投资之旅，探索我们 2946 个具有强大基本面的全球未被发现的投资宝藏。</li>
<li>拥有这些公司的股份？将您的持股整合到 Simply Wall St 的投资组合中，以获取通知和详细的股票报告。</li>
<li>通过使用 Simply Wall St，加入聪明投资者的社区。它是免费的，并提供全球市场的专家级分析。</li>
</ul>
</div><h2>Seeking Other Investments?</h2>
<div class="lb-trans"><h2>寻找其他投资机会？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力可观但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>
</div>

全球未被发现的宝石，重点介绍上海耀华皮尔金顿玻璃集团及两个有潜力的小型股